BEZZI, CAROLINA
 Distribuzione geografica
Continente #
EU - Europa 143
NA - Nord America 136
AS - Asia 84
OC - Oceania 14
Totale 377
Nazione #
US - Stati Uniti d'America 135
IT - Italia 76
CN - Cina 49
SE - Svezia 32
SG - Singapore 31
AU - Australia 14
RU - Federazione Russa 12
DE - Germania 7
FI - Finlandia 7
ID - Indonesia 3
BG - Bulgaria 2
GB - Regno Unito 2
IE - Irlanda 2
CA - Canada 1
JP - Giappone 1
NL - Olanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 377
Città #
Milan 39
New York 28
Singapore 26
Shanghai 24
Ashburn 17
Boardman 16
Moscow 9
Rome 9
Lawrence 7
Princeton 7
Dallas 6
Adelaide 5
Canberra 4
Helsinki 4
Pesaro 4
Bandung 3
Lappeenranta 3
Lissone 3
Dublin 2
Foshan 2
Jiaxing 2
Razgrad 2
Seattle 2
Sydney 2
Vigonza 2
Washington 2
Amsterdam 1
Black River Falls 1
Boston 1
Bratislava 1
Council Bluffs 1
Essen 1
Fiorano Modenese 1
Gunzenhausen 1
Hefei 1
Hessisch Oldendorf 1
Jiyuan 1
London 1
Los Angeles 1
Macerata 1
Melbourne 1
Menlo Park 1
Nanjing 1
Neyagawa 1
Romford 1
San Jose 1
Shenyang 1
Shenzhen 1
Stratford 1
Toronto 1
Torrile 1
Treviso 1
Warsaw 1
Wuhan 1
Wuhu 1
Xi'an 1
Totale 260
Nome #
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 49
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 42
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 36
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 35
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 29
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 28
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 26
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 26
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 25
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 23
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 23
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 22
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 22
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 14
Radiomics and artificial intelligence 14
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 13
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 10
Totale 437
Categoria #
all - tutte 4.742
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 6 10 6 4 2 1
2022/202397 16 15 6 8 9 6 7 11 0 13 0 6
2023/2024211 12 14 33 25 13 38 8 19 0 9 12 28
2024/2025100 23 10 23 14 30 0 0 0 0 0 0 0
Totale 437